CSIMarket
 


Clene Inc   (CLNN)
Other Ticker:  
 
 

CLNN's Revenue Growth by Quarter and Year

Clene Inc 's Revenue results by quarter and year




CLNN Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 0.17 0.23 -0.31
III Quarter September - 0.11 0.17 0.11
II Quarter June - 0.27 0.04 0.20
I Quarter March 0.07 0.11 0.03 0.00
FY   0.07 0.66 0.47 0.00



CLNN Revenue first quarter 2024 Y/Y Growth Comment
Clene Inc reported fall in Revenue in the first quarter 2024 by -33.64% to $ 0.07 millions, from the same quarter in 2023.
The drop in the first quarter 2024 Clene Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 114.83%.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 148 other companies have achieved higher Revenue growth. While Clene Inc ' s Revenue drop of -33.64% ranks overall at the positon no. 2943 in the first quarter 2024.




CLNN Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -26.09 % - -
III Quarter September - -35.29 % 54.55 % -
II Quarter June - 575 % -80 % -
I Quarter March -33.64 % 266.67 % - -
FY   - 40.43 % - -

Financial Statements
Clene Inc 's first quarter 2024 Revenue $ 0.07 millions CLNN's Income Statement
Clene Inc 's first quarter 2023 Revenue $ 0.11 millions Quarterly CLNN's Income Statement
New: More CLNN's historic Revenue Growth >>


CLNN Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 54.55 % 35.29 % -
III Quarter September - -59.26 % 325 % -45 %
II Quarter June - 145.45 % 33.33 % -
I Quarter March -57.06 % -52.17 % - -
FY (Year on Year)   - 40.43 % - -




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #149
Healthcare Sector #402
Overall #2943

Revenue Y/Y Growth Statistics
High Average Low
668.57 % 114.83 % -82.59 %
(Jun 30 2023)   (Jun 30 2022)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #149
Healthcare Sector #402
Overall #2943
Revenue Y/Y Growth Statistics
High Average Low
668.57 % 114.83 % -82.59 %
(Jun 30 2023)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Clene Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
397.14 % 48.96 % -59.85 %
(Sep 30 2022)  


CLNN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Clene Inc reported fall in Revenue from the previous quarter by -57.06% to $ 0.07 millions, from $ 0.17 millions released in the previous reporting period.

As we evaluate current downturn at the I. Quarter, we must assume, that commonly I. Quarter performance occur softer relative to the preciding period, Aadhya Rangan , market veteran located in London added.

Within Major Pharmaceutical Preparations industry 94 other companies have achieved higher Revenue quarter on quarter growth. While Clene Inc 's Revenue growth quarter on quarter, overall rank is 2087.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #95
Healthcare Sector #262
Overall #2087
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #95
Healthcare Sector #262
Overall #2087
Revenue Q/Q Growth Statistics
High Average Low
397.14 % 48.96 % -59.85 %
(Sep 30 2022)  


CLNN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Clene Inc realized fall in Revenue from the fourth quarter by -57.06% to $ 0.07 millions, from $ 0.17 millions declared in the previous reporting period.

It's not big problem, as Revenue frequently gravitate to dip in this quarter.

Within Major Pharmaceutical Preparations industry 94 other companies have achieved higher Revenue quarter on quarter growth. While Clene Inc 's Revenue growth quarter on quarter, overall rank is 2087.


Clene Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 0.62 $ 0.65 $ 0.72 $ 0.78 $ 0.55
Y / Y Revenue Growth (TTM) 12.73 % 38.27 % - - 1733.33 %
Year on Year Revenue Growth Overall Ranking # 3 # 5 # 5 # 13 # 8
Seqeuential Revenue Change (TTM) -5.2 % -8.91 % -8.42 % 42.55 % 16.28 %
Seq. Revenue Growth (TTM) Overall Ranking # 444 # 507 # 469 # 1175 # 609




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Clene Inc 's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 16.28% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Clene Inc 's Revenue growth from the 0.17% growth in Dec 31 2023.

Clene Inc achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3, from total ranking in previous quarter at 5.

Revenue TTM Q/Q Growth Statistics
High Average Low
1733.33 %
594.78 %
12.73 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 49
Healthcare Sector # 1
Overall # 3

Revenue TTM Y/Y Growth Statistics
High Average Low
1733.33 %
594.78 %
12.73 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 49
Sector # 111
S&P 500 # 444
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Clene Inc 's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 12.73% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Clene Inc 's Revenue growth from the 0.17% growth in Dec 31 2023.

Clene Inc achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3, from total ranking in previous quarter at 5.

Revenue TTM Q/Q Growth Statistics
High Average Low
1733.33 %
594.78 %
12.73 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 49
Healthcare Sector # 1
Overall # 3

Revenue TTM Y/Y Growth Statistics
High Average Low
1733.33 %
594.78 %
12.73 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 49
Sector # 111
S&P 500 # 444




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLNN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CLNN's Competitors
Revenue Growth for Clene Inc 's Suppliers
Revenue Growth for CLNN's Customers

You may also want to know
CLNN's Annual Growth Rates CLNN's Profitability Ratios CLNN's Asset Turnover Ratio CLNN's Dividend Growth
CLNN's Roe CLNN's Valuation Ratios CLNN's Financial Strength Ratios CLNN's Dividend Payout Ratio
CLNN's Roa CLNN's Inventory Turnover Ratio CLNN's Growth Rates CLNN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc -0.70%$ -0.704 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com